The long noncoding RNA (lncRNA) antisense noncoding RNA in the INK4 locus (ANRIL) expression is upregulated in hepatocellular carcinoma (HCC) tissues, and decreased ANRIL expression inhibits cell proliferation, metastasis, and invasion and induces apoptosis in HCC cells. However, the molecular mechanism by which ANRIL is involved in HCC tumorigenesis is unclear. In this study, ANRIL was found to be a significantly upregulated lncRNA in HCC and was associated with the metastasis and poor prognosis of HCC. p53 plays an important role in the mechanism of carcinogenesis. Therefore, we hypothesized that ANRIL plays a biological role by regulating the p53 signaling pathway. To comprehensively evaluate the biological function of ANRIL, bioinformatics analysis, quantitative real-time polymerase chain reaction, Western blotting, wound healing, Transwell, cell colonization assay, cell counting kit-8, reactive oxygen species, JC-1, EdU, and terminal deoxynucleotidyl transferase-mediated dUTP Nick end labeling were performed. The results showed that the knockdown of ANRIL inhibited HCC cell viability, colony forming ability, functions such as metastasis and invasion, and epithelial–mesenchymal transition. Meanwhile, the knockdown of ANRIL also resulted in the decreased expression of the p53 protein. All these effects are tightly intertwined with the regulation of the p53 signaling pathway. Thus, ANRIL may contribute to the development of new drugs for the treatment of human HCC.
CaiC, YangL, TangY, et al.Prediction of overall survival in gastric cancer using a nine-lncRNA. DNA Cell Biol, 2019; 38(9):1005–1012; doi: 10.1089/dna.2019.4832
3.
CaoC, ZhangT, ZhangD, et al.The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma. Oncogene, 2017; 36(8):1112–1122; doi: 10.1038/onc.2016.278
4.
ChaisaingmongkolJ, BudhuA, DangH, et al.; TIGER-LC Consortium. Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma. Cancer Cell, 2017; 32(1):57–70.e3; doi: 10.1016/j.ccell.2017.05.009
5.
ChenZ, YuW, ZhouQ, et al.A novel lncRNA IHS promotes tumor proliferation and metastasis in HCC by regulating the ERK- and AKT/GSK-3β-signaling pathways. Mol Ther Nucleic Acids, 2019; 16:707–720; doi: 10.1016/j.omtn.2019.04.021
6.
DengS-J, ChenH-Y, YeZ, et al.Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Oncogene, 2018; 37(44):5811–5828; doi: 10.1038/s41388-018-0382-1
7.
DongreA, WeinbergRA. New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol, 2019; 20(2):69–84; doi: 10.1038/s41580-018-0080-4
LingadahalliS, JadhaoS, SungYY, et al.Novel lncRNA LINC00844 regulates prostate cancer cell migration and invasion through AR signaling. Mol Cancer Res, 2018; 16(12):1865–1878; doi: 10.1158/1541-7786.MCR-18-0087
13.
LuZ, XiaoZ, LiuF, et al.Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1). Oncotarget, 2016; 7(1):241–254; doi: 10.18632/oncotarget.6280
14.
MaJ, LiT, HanX, et al.Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma. J Cancer Res Clin Oncol, 2018; 144(2):205–214; doi: 10.1007/s00432-017-2543-y
15.
MajidiniaM, ReiterRJ, ShakouriSK, et al.The multiple functions of melatonin in regenerative medicine. Ageing Res Rev, 2018; 45:33–52; doi: 10.1016/j.arr.2018.04.003
16.
MathyNW, ChenX-M. Long non-coding RNAs (lncRNAs) and their transcriptional control of inflammatory responses. J Biol Chem, 2017; 292(30):12375–12382; doi: 10.1074/jbc.R116.760884
17.
NisticoP, BissellMJ, RadiskyDC. Epithelial-mesenchymal transition: General principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. Cold Spring Harbor Perspectives in Biology, 2012; 4(2):a011908; doi: 10.1101/cshperspect.a011908
18.
PasmantE, SabbaghA, VidaudM, et al.ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. Faseb J, 2011; 25(2):444–448; doi: 10.1096/fj.10-172452
19.
PengS-Y, WangX-A, HuangC-Y, et al.Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus. World J Gastroenterol, 2018; 24(40):4527–4535; doi: 10.3748/wjg.v24.i40.4527
20.
PengW-X, KoiralaP, MoY-Y. LncRNA-mediated regulation of cell signaling in cancer. Oncogene, 2017; 36(41):5661–5667; doi: 10.1038/onc.2017.184
QiuJ-J, WangY, LiuY-L, et al.The long non-coding RNA ANRIL promotes proliferation and cell cycle progression and inhibits apoptosis and senescence in epithelial ovarian cancer. Oncotarget, 2016; 7(22):32478–32492; doi: 10.18632/oncotarget.8744
23.
RinonA, MolchadskyA, NathanE, et al.P53 coordinates cranial neural crest cell growth and epithelial-mesenchymal transition/delamination processes. Development, 2011; 138(9):1827–1838; doi: 10.1242/dev.053645
24.
SchoberR, SundmacherR, SchirmerM, et al.Primary intracerebral malignant lymphoma presenting with ophthalmological symptoms: Bioptical and autoptical case study. Neurosurg Rev, 1989; 12(1):63–66; doi: 10.1007/BF01787132
25.
ThieryJP, AcloqueH, HuangRYJ, et al.Epithelial-mesenchymal transitions in development and disease. Cell, 2009; 139(5):871–890; doi: 10.1016/j.cell.2009.11.007
26.
WangM-W, LiuJ, LiuQ, et al.LncRNA SNHG7 promotes the proliferation and inhibits apoptosis of gastric cancer cells by repressing the P15 and P16 expression. Eur Rev Med Pharmacol Sci, 2017; 21(20):4613–4622.
27.
WangR, MaZ, FengL, et al.LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression. Mol Cancer, 2018; 17(1):162; doi: 10.1186/s12943-018-0916-8
28.
WangY, YangL, ChenT, et al.A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Mol Cancer, 2019; 18(1):28; doi: 10.1186/s12943-019-0957-7
29.
XiS-Y, MinukGY. Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma. World J Hepatol, 2018; 10(11):799–806; doi: 10.4254/wjh.v10.i11.799
30.
YangJD, HainautP, GoresGJ, et al.A global view of hepatocellular carcinoma: Trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol, 2019; 16(10):589–604; doi: 10.1038/s41575-019-0186-y
31.
YapKL, LiS, Muñoz-CabelloAM, et al.Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell, 2010; 38(5):662–674; doi: 10.1016/j.molcel.2010.03.021
32.
YuL, FangF, LuS, et al.lncRNA-HIT promotes cell proliferation of non-small cell lung cancer by association with E2F1. Cancer Gene Ther, 2017; 24(5):221–226; doi: 10.1038/cgt.2017.10
33.
ZhuL-Y, ZhuY-R, DaiD-J, et al.Epigenetic regulation of alternative splicing. Am J Cancer Res, 2018; 8(12):2346–2358.
